vs
Ameren（AEE）与Encompass Health Corp（EHC）财务数据对比。点击上方公司名可切换其他公司
Ameren的季度营收约是Encompass Health Corp的1.2倍（$1.8B vs $1.5B），Ameren净利率更高（14.2% vs 9.5%，领先4.7%），Encompass Health Corp同比增速更快（9.9% vs -8.2%），Encompass Health Corp自由现金流更多（$116.7M vs $-54.0M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -0.9%）
Ameren Corporation是美国公共事业控股企业，下设Ameren密苏里、伊利诺伊州配电、伊利诺伊州天然气、输电四大业务板块，主营受费率监管的发电、输电、配电业务，以及受监管的天然气输配业务，电力生产主要采用煤炭、核电等能源。
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
AEE vs EHC — 直观对比
营收规模更大
AEE
是对方的1.2倍
$1.5B
营收增速更快
EHC
高出18.1%
-8.2%
净利率更高
AEE
高出4.7%
9.5%
自由现金流更多
EHC
多$170.7M
$-54.0M
两年增速更快
EHC
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.5B |
| 净利润 | $253.0M | $146.1M |
| 毛利率 | — | — |
| 营业利润率 | 20.2% | 16.7% |
| 净利率 | 14.2% | 9.5% |
| 营收同比 | -8.2% | 9.9% |
| 净利润同比 | 21.6% | 20.8% |
| 每股收益（稀释后） | $0.92 | $1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEEEHC
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $2.7B | $1.5B | ||
| Q2 25 | $2.2B | $1.5B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $2.2B | $1.4B | ||
| Q2 24 | $1.7B | $1.3B | ||
| Q1 24 | $1.8B | $1.3B |
净利润AEEEHC
| Q4 25 | $253.0M | $146.1M | ||
| Q3 25 | $641.0M | $126.5M | ||
| Q2 25 | $277.0M | $142.1M | ||
| Q1 25 | $290.0M | $151.5M | ||
| Q4 24 | $208.0M | $120.9M | ||
| Q3 24 | $457.0M | $108.2M | ||
| Q2 24 | $260.0M | $114.1M | ||
| Q1 24 | $262.0M | $112.5M |
营业利润率AEEEHC
| Q4 25 | 20.2% | 16.7% | ||
| Q3 25 | 30.6% | 14.9% | ||
| Q2 25 | 18.5% | 16.2% | ||
| Q1 25 | 20.5% | 16.4% | ||
| Q4 24 | 10.2% | 14.3% | ||
| Q3 24 | 27.0% | 13.6% | ||
| Q2 24 | 21.3% | 14.3% | ||
| Q1 24 | 20.4% | 13.6% |
净利率AEEEHC
| Q4 25 | 14.2% | 9.5% | ||
| Q3 25 | 23.7% | 8.6% | ||
| Q2 25 | 12.5% | 9.7% | ||
| Q1 25 | 13.8% | 10.4% | ||
| Q4 24 | 10.7% | 8.6% | ||
| Q3 24 | 21.0% | 8.0% | ||
| Q2 24 | 15.4% | 8.8% | ||
| Q1 24 | 14.4% | 8.5% |
每股收益（稀释后）AEEEHC
| Q4 25 | $0.92 | $1.43 | ||
| Q3 25 | $2.35 | $1.24 | ||
| Q2 25 | $1.01 | $1.39 | ||
| Q1 25 | $1.07 | $1.48 | ||
| Q4 24 | $0.77 | $1.18 | ||
| Q3 24 | $1.70 | $1.06 | ||
| Q2 24 | $0.97 | $1.12 | ||
| Q1 24 | $0.98 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.0M | $72.2M |
| 总债务越低越好 | $19.4B | $2.4B |
| 股东权益账面价值 | $13.4B | $2.4B |
| 总资产 | $48.5B | $7.1B |
| 负债/权益比越低杠杆越低 | 1.45× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资AEEEHC
| Q4 25 | $13.0M | $72.2M | ||
| Q3 25 | $9.0M | $48.7M | ||
| Q2 25 | $11.0M | $99.1M | ||
| Q1 25 | $23.0M | $95.8M | ||
| Q4 24 | $7.0M | $85.4M | ||
| Q3 24 | $17.0M | $147.8M | ||
| Q2 24 | $19.0M | $154.4M | ||
| Q1 24 | $85.0M | $134.4M |
总债务AEEEHC
| Q4 25 | $19.4B | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | $17.8B | $2.4B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
股东权益AEEEHC
| Q4 25 | $13.4B | $2.4B | ||
| Q3 25 | $12.8B | $2.4B | ||
| Q2 25 | $12.3B | $2.3B | ||
| Q1 25 | $12.2B | $2.2B | ||
| Q4 24 | $12.1B | $2.1B | ||
| Q3 24 | $11.8B | $2.0B | ||
| Q2 24 | $11.5B | $1.8B | ||
| Q1 24 | $11.4B | $1.7B |
总资产AEEEHC
| Q4 25 | $48.5B | $7.1B | ||
| Q3 25 | $47.4B | $6.9B | ||
| Q2 25 | $46.6B | $6.8B | ||
| Q1 25 | $45.7B | $6.6B | ||
| Q4 24 | $44.6B | $6.5B | ||
| Q3 24 | $43.3B | $6.5B | ||
| Q2 24 | $42.3B | $6.4B | ||
| Q1 24 | $41.3B | $6.2B |
负债/权益比AEEEHC
| Q4 25 | 1.45× | 1.00× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | 1.47× | 1.14× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $956.0M | $346.0M |
| 自由现金流经营现金流 - 资本支出 | $-54.0M | $116.7M |
| 自由现金流率自由现金流/营收 | -3.0% | 7.6% |
| 资本支出强度资本支出/营收 | 56.7% | 14.8% |
| 现金转化率经营现金流/净利润 | 3.78× | 2.37× |
| 过去12个月自由现金流最近4个季度 | $-775.0M | $439.2M |
8季度趋势，按日历期对齐
经营现金流AEEEHC
| Q4 25 | $956.0M | $346.0M | ||
| Q3 25 | $1.1B | $270.8M | ||
| Q2 25 | $862.0M | $270.2M | ||
| Q1 25 | $431.0M | $288.6M | ||
| Q4 24 | $817.0M | $278.8M | ||
| Q3 24 | $897.0M | $267.8M | ||
| Q2 24 | $557.0M | $217.4M | ||
| Q1 24 | $492.0M | $238.8M |
自由现金流AEEEHC
| Q4 25 | $-54.0M | $116.7M | ||
| Q3 25 | $116.0M | $83.7M | ||
| Q2 25 | $-204.0M | $113.3M | ||
| Q1 25 | $-633.0M | $125.5M | ||
| Q4 24 | $-473.0M | $80.1M | ||
| Q3 24 | $-240.0M | $120.3M | ||
| Q2 24 | $-445.0M | $60.5M | ||
| Q1 24 | $-398.0M | $99.4M |
自由现金流率AEEEHC
| Q4 25 | -3.0% | 7.6% | ||
| Q3 25 | 4.3% | 5.7% | ||
| Q2 25 | -9.2% | 7.8% | ||
| Q1 25 | -30.2% | 8.6% | ||
| Q4 24 | -24.4% | 5.7% | ||
| Q3 24 | -11.0% | 8.9% | ||
| Q2 24 | -26.3% | 4.6% | ||
| Q1 24 | -21.9% | 7.6% |
资本支出强度AEEEHC
| Q4 25 | 56.7% | 14.8% | ||
| Q3 25 | 36.6% | 12.7% | ||
| Q2 25 | 48.0% | 10.8% | ||
| Q1 25 | 50.7% | 11.2% | ||
| Q4 24 | 66.5% | 14.1% | ||
| Q3 24 | 52.3% | 10.9% | ||
| Q2 24 | 59.2% | 12.1% | ||
| Q1 24 | 49.0% | 10.6% |
现金转化率AEEEHC
| Q4 25 | 3.78× | 2.37× | ||
| Q3 25 | 1.72× | 2.14× | ||
| Q2 25 | 3.11× | 1.90× | ||
| Q1 25 | 1.49× | 1.90× | ||
| Q4 24 | 3.93× | 2.31× | ||
| Q3 24 | 1.96× | 2.48× | ||
| Q2 24 | 2.14× | 1.91× | ||
| Q1 24 | 1.88× | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEE
暂无分部数据
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
